Evidence map›Paper›PMID 40023159›Full record

ArticleImmunity2025

Splenic TNF-α signaling potentiates the innate-to-adaptive transition of antiviral NK cells.

Adriana M Mujal, Mark Owyong, Endi K Santosa, John C Sauter, Simon Grassmann, Anna-Marie Pedde, Philippa Meiser, Claire K Wingert, Marine Pujol, Veit R Buchholz and 3 more

Abstract read
In one paragraph

Article in Immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. 1,25-Dihydroxy vitamin DAnnals of medicine · 2025
    Article
  11. Article
  12. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  13. Article
  14. NK cells in HPV-related tumorigenesis: mechanisms and clinical applications.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Glycyrrhiza polysaccharide attenuatesFrontiers in veterinary science · 2025
    Article
  16. Frontiers in pharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Adriana M MujalImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: mujala@mskcc.org.
Mark OwyongImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY, USA.
Endi K SantosaImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY, USA.
John C SauterImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Simon GrassmannImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Anna-Marie PeddeDepartment of Experimental Immunology, Institute of Immunology, University of Tübingen, Tübingen, Germany; M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Philippa MeiserInstitute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Claire K WingertImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marine PujolInstitute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Veit R BuchholzInstitute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Colleen M LauImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jan P BöttcherDepartment of Experimental Immunology, Institute of Immunology, University of Tübingen, Tübingen, Germany; M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Joseph C SunImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY, USA. Electronic address: sunj@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
Transcriptional control of NK cell metabolismR01AI155558 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2021 to 2026
$4.7M
IMMUNOLOGY RESEARCH TRAININGT32CA009149 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RUDENSKY, ALEXANDER Y · 1985 to 2022
$4.0M
Regulation of Nfil3 in innate lymphocyte-mediated host immunityR01AI130043 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SUN, JOSEPH CHAI-YUEN · 2017 to 2021
$2.8M
Immunology and Microbial Pathogenesis Research Training ProgramT32AI134632 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI EHRT, SABINE, LI, MING · 2019 to 2023
$747k
Role of Frizzled 5 in NK cell development and antiviral host immunityF31AI178958 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Mark Owyong · 2023 to 2026
$147k
NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA009149NIAID NIH HHS F31 AI178958NIAID NIH HHS R01 AI100874NIAID NIH HHS R01 AI130043NIAID NIH HHS R01 AI155558NIAID NIH HHS T32 AI134632
6 · The paper itself

Abstract

Natural killer (NK) cells possess both innate and adaptive features. Here, we investigated NK cell activation across tissues during cytomegalovirus infection, which generates antigen-specific clonal expansion and long-lived memory responses. Longitudinal tracking and single-cell RNA sequencing of NK cells following infection revealed enhanced activation in the spleen, as well as early formation of a CD69

Indexed as

Cytomegalovirus InfectionsImmunity, InnateKiller Cells, NaturalSpleenTumor Necrosis Factor-alphaAdaptive ImmunityAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensInterferon-gammaLectins, C-TypeLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensInterferon-gammaLectins, C-TypeNF-kappa BReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor-alphaMCMVNF-κB signalingNIKNK cellsTNFR2TNF-α

Identifiers

PMID40023159
PMCPMC12668197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.